Newsroom
News from UCLB
UCLB Spinout Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
UCLB spinout company, Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative ...
Recent coverage of UCLB spinout Hazy’s extra $1.8m in seed funding, led by UCL Technology Fund
Data anonymisation software developer, Hazy gained coverage in The Telegraph’s Technology Intelligence pages, in light of the $1.8m it has ...
Endomagnetics Ltd secures $10m (£8m) funding to establish better breast cancer care
UCLB spinout company, Endomagnetics Ltd, who are developing a portfolio of products to improve the standard of breast cancer management, ...
UCLB Toasts 25 Years of UCL Innovation at its Annual Summer Reception
Thursday the 5th July saw UCLB host its annual summer reception event, celebrating some of the remarkable achievements of the ...
£265 million investment in UCL spin-outs which could transform patient outcomes
Three UCL spin-out companies focused on delivering advanced therapeutics to treat a range of diseases received a substantial amount of ...
UCL computer vision spin-out acquired by Niantic Inc.
UCL spin-out Matrix Mill Ltd, a company specialising in applying artificial intelligence and machine vision research to solve industry problems, ...
Matrix Mill’s Acquisition by Niantic Features in BBC News
BBC News technology reporter Dave Lee, discusses Niantic’s recent acquisition of UCL Computer Science spinout Matrix Mill. Niantic’s acquisition of ...
Autolus announces closing of Initial Public Offering
UCLB Spinout, Autolus announces closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American ...
Autolus announces the pricing of its initial public offering
UCLB spinout, Autolus, announced today the pricing of its initial public offering in the United States of 8,823,530 American Depositary Shares ...
Matr raises £4.75 million for AI teaching platform
Matr, the online teaching platform, has announced it has closed a £4.75 million Series A investment round led by the ...
Fortress Biotech Announces Publication of Phase 1 Data on CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia in Biology of Blood and Marrow Transplantation
Fortress Biotech, formerly Coronado Biosciences Inc, announces publication in the journal Biology of Blood and Marrow Transplantation of positive Phase ...
Freeline secures over £88 million of funding
London, 19 June 2018 – Freeline Therapeutics Ltd (“Freeline”), a clinical stage company focused on treatment of chronic systemic diseases with ...
UCL SPINOUT MEIRAGTX ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING
UCL Spinout MeiraGTx Holdings plc a vertically integrated, clinical stage gene therapy company, announced the closing of its initial public ...
UCL TECHNOLOGY FUND HAS APPROVED INVESTMENT OF UP TO £1M IN THE DEVELOPMENT OF A GENE THERAPY FOR (PERFORIN DEFICIENT) FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
The UCL Technology Fund (UCLTF) has approved an investment of up to £1m to support Professor Bobby Gaspar’s development of ...
UCL Technology Fund Holds 2018 Showcase Event
On Thursday 3rd May, the UCL Technology Fund hosted a showcase event, in celebration of the first two years of ...
